FOXM1 and cancer: Hamurcu Z et al. discovered that FOXM1 can upregulate miR-186-5p and downregulate miR-200b-5p, leading to adverse outcomes in TNBC cells: the miR-186-5p is recognized as an oncogenic miRNA that promotes cancer cells progression by regulating Beclin-1.